THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
Positive with limitationsNarrative and translational review of mechanistic, neuroimaging and clinical evidence

Repetitive transcranial magnetic stimulation (rTMS) combined with antidepressant pharmacotherapy for depression: state-dependent mechanisms, clinical evidence, and translational challenges

Published October 18, 2026. The review describes encouraging evidence that combining rTMS with antidepressant medication may improve the timing or durability of response for some people. It also emphasizes that the interaction is not uniformly additive and may depend on medication, stimulation protocol, brain state and individual context.

Deng J, Shao Y, Jiang L, Wu B, Roberts N, Wang Q, Jia Z.
Molecular Psychiatry · Publication date: 2026-10-18
Added to site: 2026-10-20
DOI: 10.1038/s41380-026-03930-8

Published October 18, 2026. Added to Neurofeedback.com October 20, 2026.

Modalities
rTMS, TMS, Antidepressant pharmacotherapy
Clinical focus
Depression, Combination treatment, State-dependent mechanisms
Population
People with depression represented across the clinical studies discussed by the review
Sample
Previously published mechanistic, neuroimaging and clinical studies; no new participants or pooled denominator were reported in the checked abstract
Intervention / method
The review examines how antidepressant class, rTMS protocol and timing, cortical excitability, metaplasticity and individual context may shape combined-treatment effects.
Comparator
Comparators varied across the underlying literature; this narrative review did not report a single pooled active or sham comparison in the checked abstract

Clinician summary

The authors integrate state-dependent neurophysiology with heterogeneous clinical evidence. They describe possible gains in early improvement, response, remission and relapse prevention, while emphasizing expectancy and sham-blinding problems, protocol and medication heterogeneity, and the need for biomarker-informed targeting. The checked abstract provides no pooled effect estimate or formal certainty rating.

How to interpret the findings

This is a narrative review rather than a new randomized trial or a reported meta-analysis. The checked abstract does not describe a systematic search, pooled denominator, quantitative effect estimate or formal certainty assessment. Underlying evidence is heterogeneous, expectancy and sham blinding remain important limitations, and the proposed mechanisms are not proven clinical mediators.

Equipment and disclosures

No single stimulation system or manufacturer represents the evidence summarized by this review. No BrainMaster attribution.

Supported by National Natural Science Foundation of China grants 82471953, 82271947 and 82502501, the West China Hospital 1·3·5 project, the CAMS Innovation Fund for Medical Sciences and the Chengdu Science and Technology Program. The authors declared no competing interests. No indexed correction, retraction or concern relation appeared in the retained Crossref record; this is a bounded check. AI-assisted review.

Related evidence

Compare findings from the same clinical area, including mixed results.

Abstract checked · Checked 2026-10-20

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.